Suppr超能文献

糖皮质激素与肿瘤浸润淋巴细胞在肾上腺皮质癌预后中的相互作用。

Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma.

机构信息

Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Würzburg, Würzburg, Germany.

Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany.

出版信息

J Immunother Cancer. 2020 May;8(1). doi: 10.1136/jitc-2019-000469.

Abstract

BACKGROUND

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Tumor-related glucocorticoid excess is present in ~60% of patients and associated with particularly poor prognosis. Results of first clinical trials using immune checkpoint inhibitors were heterogeneous. Here we characterize tumor-infiltrating T lymphocytes (TILs) in ACC in association with glucocorticoids as potential explanation for resistance to immunotherapy.

METHODS

We performed immunofluorescence analysis to visualize tumor-infiltrating T cells (CD3), T helper cells (CD3CD4), cytotoxic T cells (CD3CD8) and regulatory T cells (Tregs; CD3CD4FoxP3) in 146 ACC tissue specimens (107 primary tumors, 16 local recurrences, 23 metastases). Quantitative data of immune cell infiltration were correlated with clinical data (including glucocorticoid excess).

RESULTS

86.3% of ACC specimens showed tumor infiltrating T cells (7.7 cells/high power field (HPF)), including T helper (74.0%, 6.7 cells/HPF), cytotoxic T cells (84.3%, 5.7 cells/HPF) and Tregs (49.3%, 0.8 cells/HPF). The number of TILs was associated with better overall survival (HR for death: 0.47, 95% CI 0.25 to 0.87), which was true for CD4- and CD8 subpopulations as well. In localized, non-metastatic ACC, the favorable impact of TILs on overall and recurrence-free survival was manifested even independently of ENSAT (European Network for the Study of Adrenal Tumors) stage, resection status and Ki67 index. T helper cells were negatively correlated with glucocorticoid excess (Phi=-0.290, p=0.009). Patients with glucocorticoid excess and low TILs had a particularly poor overall survival (27 vs. 121 months in patients with TILs without glucocorticoid excess).

CONCLUSION

Glucocorticoid excess is associated with T cell depletion and unfavorable prognosis. To reactivate the immune system in ACC by checkpoint inhibitors, an inhibition of adrenal steroidogenesis might be pivotal and should be tested in prospective studies.

摘要

背景

肾上腺皮质癌(ACC)是一种罕见的内分泌恶性肿瘤。约 60%的患者存在与肿瘤相关的糖皮质激素过多,并与预后特别差相关。首次使用免疫检查点抑制剂的临床试验结果存在异质性。在这里,我们描述了与糖皮质激素相关的 ACC 中的肿瘤浸润 T 淋巴细胞(TIL),这可能是免疫治疗耐药的潜在解释。

方法

我们对 146 例 ACC 组织标本(107 例原发性肿瘤、16 例局部复发、23 例转移)进行免疫荧光分析,以可视化肿瘤浸润 T 细胞(CD3)、辅助性 T 细胞(CD3CD4)、细胞毒性 T 细胞(CD3CD8)和调节性 T 细胞(Tregs;CD3CD4FoxP3)。免疫细胞浸润的定量数据与临床数据(包括糖皮质激素过多)相关。

结果

86.3%的 ACC 标本显示肿瘤浸润 T 细胞(7.7 个/高倍视野(HPF)),包括辅助性 T 细胞(74.0%,6.7 个/HPF)、细胞毒性 T 细胞(84.3%,5.7 个/HPF)和 Tregs(49.3%,0.8 个/HPF)。TIL 数量与总生存时间相关(死亡风险比:0.47,95%CI 0.25 至 0.87),CD4 和 CD8 亚群也是如此。在局限性、非转移性 ACC 中,TIL 对总生存和无复发生存的有利影响甚至在独立于欧洲肾上腺肿瘤研究网络(ENSAT)分期、切除状态和 Ki67 指数的情况下也表现出来。辅助性 T 细胞与糖皮质激素过多呈负相关(Phi=-0.290,p=0.009)。存在糖皮质激素过多和 TIL 较低的患者总生存时间特别差(糖皮质激素过多的患者与 TIL 无糖皮质激素过多的患者相比,分别为 27 个月和 121 个月)。

结论

糖皮质激素过多与 T 细胞耗竭和不良预后相关。为了通过免疫检查点抑制剂重新激活 ACC 中的免疫系统,抑制肾上腺类固醇生成可能是关键的,应该在前瞻性研究中进行测试。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ef/7264832/4fceac155550/jitc-2019-000469f01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验